Trials / Recruiting
RecruitingNCT06344091
A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients
A Real World Study on Local Infiltration of Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic Surgery
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 232 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety and efficacy of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery in the real world.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine Liposome Injection | Bupivacaine Liposome Injection 4 mg/kg (up to a maximum of 266 mg) |
Timeline
- Start date
- 2024-05-21
- Primary completion
- 2026-09-28
- Completion
- 2026-10-12
- First posted
- 2024-04-03
- Last updated
- 2025-10-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06344091. Inclusion in this directory is not an endorsement.